About Us

Introduction

The American College of Neuropsychopharmacology (ACNP), founded in 1961, is the nation's premier professional society in brain, behavior, and psychopharmacology research. The field of neuropsychopharmacology involves the evaluation of the effects of natural and synthetic compounds upon the brain, mind, and human behavior. 

Mission Statement, Core Purpose, Core Values
A summary of our mission and core values.

About the ACNP (PDF 3148Kb)
An article by Oakley Ray, originally published in Academic Psychiatry.

ACNP Perspective (PDF 1555Kb)
An article by Ira Glick, originally published in Academic Psychiatry.

ACNP Financial Disclosure & COI Firewalls

The core purpose of the ACNP is to advance scientific understanding of and to facilitate communication about disorders of the brain and behavior in order to further their prevention and treatment. The ACNP has historically provided a venue at which the best scientists from academia, government, and industry have gathered to share, discuss, and debate their research. The meeting has served as a catalyst to advance discovery and disseminate information about scientific advances.

Like most professional medical societies, funding for the ACNP comes from a variety of sources including membership dues, royalties from publication sales, meeting registration fees, and grants from corporations or governmental agencies. The College has developed policies and procedures to either eliminate or to properly manage both real and perceived conflicts of interest, and to separate financial issues from operational decisions.  We have established firewalls to protect the integrity of College operations and to prevent the influence of financial sponsors from penetrating decision making processes of the College.

Click here to view some of these measures.

Participating Corporations

Click here to learn more about the ACNP Participating Corporation Program. 
 
The American College of Neuropsychopharmacology appreciates the support of our participating corporations:

Abbvie Laboratories
Alkermes, Inc.
Amgen, USA 
Astellas Pharma
Eisai Medical Research, Inc.
Eli Lilly and Company
EnVivo Pharmaceuticals
Forest Laboratories, Inc.
Genentech
H. Lundbeck A/S, Denmark
Hoffmann-LaRoche, Inc.
Janssen Pharmaceutica Products, L.P.
Merck
Novartis Pharmaceuticals Corporation
Otsuka Pharmaceutical Development, Inc.
Otsuka America Pharmaceuticals, Inc.
Sunovion Pharmaceuticals, Inc.
Takeda Pharmaceuticals
Targacept, Inc.
 

Annual Meeting

Program CoverThe ACNP Annual Meeting is one of the world's leading forums for the exchange of cutting edge scientific information about the brain, behavior, and psychotropic drugs.

Research Discussions

This forum enables discussion of articles that have appeared in Neuropsychopharmacology. It is intended to stimulate scholarly interactions among researchers, and to help educate members of the public who are interested in psychiatric illness.

ACNP Publications

Program CoverThe College offers a variety of Publications with the latest and most comprehensive research in psychopharmacology and related fields.